blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3911410

EP3911410 - METHODS AND SYSTEMS FOR PRODUCING AAV PARTICLES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  22.10.2021
Database last updated on 03.10.2024
FormerThe international publication has been made
Status updated on  25.07.2020
Formerunknown
Status updated on  28.02.2020
Most recent event   Tooltip23.01.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Voyager Therapeutics, Inc.
75 Sidney Street
Cambridge, Massachusetts 02139 / US
[2021/47]
Inventor(s)01 / MARANGA, Luis
c/o Voyager Therapeutics, Inc.
75 Sidney Street
Cambridge, Massachusetts 02139 / US
02 / MORRISON, Christopher J.
c/o Voyager Therapeutics, Inc.
75 Sidney Street
Cambridge, Massachusetts 02139 / US
03 / MATHUR, Krishanu
c/o Voyager Therapeutics, Inc.
75 Sidney Street
Cambridge, Massachusetts 02139 / US
04 / LUTHER, Matthew
c/o Voyager Therapeutics, Inc.
75 Sidney Street
Cambridge, Massachusetts 02139 / US
05 / HURWIT, Daniel S.
c/o Voyager Therapeutics, Inc.
75 Sidney Street
Cambridge, Massachusetts 02139 / US
06 / CARDINAL, Jacob J.
c/o Voyager Therapeutics, Inc.
75 Sidney Street
Cambridge, Massachusetts 02139 / US
07 / KARPES, Lori B.
32 Roberts Road
Ashland, Massachusetts 01721 / US
08 / ANSONDARIA, Aditya
c/o Voyager Therapeutics, Inc.
75 Sidney Street
Cambridge, Massachusetts 02139 / US
09 / FORSTER, James
c/o Voyager Therapeutics, Inc.
75 Sidney Street
Cambridge, Massachusetts 02139 / US
10 / DISMUKE, David
414 Selwood Place
Cary, North Carolina 27519 / US
11 / STEININGER, Robert
100 Reed Street
Cambridge, Massachusetts 02140 / US
[N/P]
Former [2021/47]01 / MARANGA, Luis
Cambridge, Massachusetts 02139 / US
02 / MORRISON, Christopher J.
Cambridge, Massachusetts 02139 / US
03 / MATHUR, Krishanu
Cambridge, Massachusetts 02139 / US
04 / LUTHER, Matthew
Cambridge, Massachusetts 02139 / US
05 / HURWIT, Daniel S.
Cambridge, Massachusetts 02139 / US
06 / CARDINAL, Jacob J.
Cambridge, Massachusetts 02139 / US
07 / KARPES, Lori B.
Ashland, Massachusetts 01721 / US
08 / ANSONDARIA, Aditya
Cambridge, Massachusetts 02139 / US
09 / FORSTER, James
Cambridge, Massachusetts 02139 / US
10 / DISMUKE, David
Cary, North Carolina 27519 / US
11 / STEININGER, Robert
Cambridge, Massachusetts 02140 / US
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2021/47]
Application number, filing date20705569.017.01.2020
[2021/47]
WO2020US14000
Priority number, dateUS201962794199P18.01.2019         Original published format: US 201962794199 P
US201962794204P18.01.2019         Original published format: US 201962794204 P
US201962794208P18.01.2019         Original published format: US 201962794208 P
US201962794216P18.01.2019         Original published format: US 201962794216 P
US201962931848P07.11.2019         Original published format: US 201962931848 P
[2021/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020150556
Date:23.07.2020
Language:EN
[2020/30]
Type: A1 Application with search report 
No.:EP3911410
Date:24.11.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 23.07.2020 takes the place of the publication of the European patent application.
[2021/47]
Search report(s)International search report - published on:EP23.07.2020
ClassificationIPC:A61P25/14, C12N15/86
[2021/47]
CPC:
A61P25/14 (EP,IL); C12N15/86 (EP,IL,US); A61K48/005 (US);
C12N2710/14052 (EP); C12N2750/14143 (EP,US); C12N2750/14151 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/47]
TitleGerman:VERFAHREN UND SYSTEME ZUR HERSTELLUNG VON AAV-PARTIKELN[2021/47]
English:METHODS AND SYSTEMS FOR PRODUCING AAV PARTICLES[2021/47]
French:PROCÉDÉS ET SYSTÈMES DE FABRICATION DE PARTICULES AAV[2021/47]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase27.07.2021National basic fee paid 
27.07.2021Designation fee(s) paid 
27.07.2021Examination fee paid 
Examination procedure27.07.2021Examination requested  [2021/47]
27.07.2021Date on which the examining division has become responsible
19.04.2022Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
22.06.2022Amendment by applicant (claims and/or description)
Request for further processing for:22.06.2022Request for further processing filed
22.06.2022Full payment received (date of receipt of payment)
Request granted
27.06.2022Decision despatched
Fees paidRenewal fee
07.09.2021Renewal fee patent year 03
31.10.2022Renewal fee patent year 04
23.01.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[YD]WO0212455  (AVIGEN INC [US]) [YD] 1-19 * abstract *;
 [XY]WO2016004319  (UNIV FLORIDA [US]) [X] 20-22 * abstract * * page 1, line 25 - page 5, line 18 * * page 9, line 8 - page 11, line 14 * * page 17, line 25 - page 19, line 19 * * page 39, line 23 - page 40, line 8; figure 1; example 1 * [Y] 1-19;
 [XY]WO2017201258  (VOYAGER THERAPEUTICS INC [US]) [X] 20-22 * abstract * * paragraph [0029] - paragraph [0040] * * paragraph [0417] - paragraph [0452] * * paragraph [0453] - paragraph [0471] * * paragraph [0498] - paragraph [0535]; examples 1,8; table 11 * [Y] 1-19;
 [Y]  - NEGRETE ET AL, "Production of recombinant adeno-associated vectors using two bioreactor configurations at different scales", JOURNAL OF VIROLOGICAL METHODS, ELSEVIER BV, NL, (20070831), vol. 145, no. 2, doi:10.1016/J.JVIROMET.2007.05.020, ISSN 0166-0934, pages 155 - 161, XP022226046 [Y] 1-19 * abstract * * page 156, column 1, paragraph 3 - page 157, column 1, paragraph 2 * * page 158, column 2, paragraph 4 - page 159, column 1, paragraph 2 *

DOI:   http://dx.doi.org/10.1016/j.jviromet.2007.05.020
 [Y]  - OTTO-WILHELM MERTEN, "AAV vector production: state of the art developments and remaining challenges", CELL AND GENE THERAPY INSIGHTS, (20161201), vol. 2, no. 5, doi:10.18609/cgti.2016.067, ISSN 2059-7800, pages 521 - 551, XP055649764 [Y] 1-19 * abstract * * page 533, column 2 - page 537, column 1, paragraph 1 * * page 542, column 2, paragraph 3 - page 543, column 2, paragraph 2; figure 4 *

DOI:   http://dx.doi.org/10.18609/cgti.2016.067
 [Y]  - WEIHONG QU ET AL, "Scalable Downstream Strategies for Purification of Recombinant Adeno- Associated Virus Vectors in Light of the Properties", CURRENT PHARMACEUTICAL BIOTECHNOLOGY, NL, (20150101), vol. 16, doi:10.2174/1389201016666150505122228, ISSN 1389-2010, pages 684 - 695, XP055533837 [Y] 1-19 * abstract * * page 685, column 1 * * figure 5; table 1 *

DOI:   http://dx.doi.org/10.2174/1389201016666150505122228
 [Y]  - R. M. KOTIN, "Large-scale recombinant adeno-associated virus production", HUMAN MOLECULAR GENETICS, (20110415), vol. 20, no. R1, doi:10.1093/hmg/ddr141, ISSN 0964-6906, pages R2 - R6, XP055016870 [Y] 1-19 * abstract * * page r4, column 1, paragraph 3 - page r5, column 1, paragraph 1 *

DOI:   http://dx.doi.org/10.1093/hmg/ddr141
 [Y]  - CECCHINI S ET AL, "Toward exascale production of recombinant adeno-associated virus for gene transfer applications", GENE THERAPY, NATURE PUBLISHING GROUP, LONDON, GB, vol. 15, no. 11, doi:10.1038/GT.2008.61, ISSN 0969-7128, (20080601), pages 823 - 830, (20080410), XP002679918 [Y] 1-19 * abstract * * page 827, column 2, paragraph 5 - page 828, column 2, paragraph 1; figure 4 *

DOI:   http://dx.doi.org/10.1038/gt.2008.61
 [Y]  - TAMAS VIRAG ET AL, "Producing Recombinant Adeno-Associated Virus in Foster Cells: Overcoming Production Limitations Using a Baculovirus-Insect Cell Expression Strategy", HUMAN GENE THERAPY, (20090801), vol. 20, no. 8, doi:10.1089/hum.2009.092, ISSN 1043-0342, pages 807 - 817, XP055052744 [Y] 1-19 * abstract * * page 811, column 1, paragraph 3 - column 2, paragraph 2 * * page 814, column 2, paragraph 2 - page 815; figure 4 *

DOI:   http://dx.doi.org/10.1089/hum.2009.092
 [A]  - HANNA P LESCH ET AL, "Requirements for baculoviruses for clinical gene therapy applications", JOURNAL OF INVERTEBRATE PATHOLOGY, vol. 107, doi:10.1016/J.JIP.2011.05.010, ISSN 0022-2011, (20110101), pages S106 - S112, (20110506), XP028244451 [A] 1-22 * abstract * * page s108, column 2, paragraph 2 - page s109, column 1, paragraph 2; figure 1; table 1 *

DOI:   http://dx.doi.org/10.1016/j.jip.2011.05.010
 [A]  - AUCOIN MARC G ET AL, "Virus-like particle and viral vector production using the baculovirus expression vector system/insect cell system: adeno-associated virus-based products", ANTIBODY-DRUG CONJUGATES; IN: METHODS IN MOLECULAR BIOLOGY; ISSN 1064-3745; VOL. 1045; [METHODS IN MOLECULAR BIOLOGY; ISSN 1064-3745; VOL. 1045], HUMANA PRESS, US, (20070101), vol. 388, ISBN 978-1-62703-541-5, pages 281 - 296, XP009151013 [A] 1-22 * abstract *
by applicantUS4946778
 US5064764
 US5387484
 US5525491
 WO9617947
 WO9639530
 US5688676
 US5691176
 WO9810088
 WO9811244
 EP0835321
 US5741683
 US5756283
 US5856456
 WO9914354
 WO9915685
 EP0931158
 WO9947691
 EP0950111
 WO0024916
 WO0028004
 EP1015619
 WO0047757
 WO0055342
 US6143567
 US6143548
 US6146874
 US6156303
 WO0075353
 EP1064393
 US6180613
 US6194191
 US6204059
 US6211163
 WO0123001
 WO0123597
 US6258595
 US6261551
 US6265389
 US6270996
 US6274354
 US6281010
 WO0189583
 EP1163354
 US2002019050
 WO0212455
 EP1183380
 US6365394
 US6410300
 US2002081721
 US2002090717
 EP1226264
 US2002102714
 US6428988
 US6436394
 US6436708
 US6475769
 US6482634
 US6485966
 US6503888
 US6506379
 US2003032613
 US2003040101
 US2003073232
 US6555525
 US2003092161
 US6566118
 US2003119191
 US6593123
 US2003138772
 US6660521
 US6660514
 US6676935
 US6699706
 US6726907
 WO2004112727
 WO2005003332
 WO2005005610
 WO2005033321
 WO2005072364
 US6943019
 US6953690
 US2006003451
 US6995006
 US7015026
 EP1636370
 US7022519
 US7048920
 US7091030
 US7094604
 US2006211115
 US7125706
 US2007004042
 EP1752536
 US7198951
 WO2007046703
 US7223585
 US7238526
 US2007231303
 US7291498
 US7300797
 WO2007148971
 US7326555
 WO2008052322
 US7419956
 US7419817
 US7427396
 US7445930
 EP2018421
 US7491508
 US7510875
 US7579181
 WO2009104964
 US7588772
 US7588757
 US2009275107
 US7625570
 US7704721
 US2010130594
 US7732129
 US2010240739
 US7888096
 US7901921
 US2011136227
 US2011151434
 US7968333
 US2011171262
 US2011212529
 US2011229971
 US2011263027
 US8110351
 US8119611
 US8137948
 US8163543
 WO2012057363
 US8236495
 US8283151
 US2012264807
 US2013019580
 US2013023034
 US2013045186
 US8476418
 US8512981
 US8524446
 US2013323302
 US8614101
 EP2678433
 US8642314
 US2014087361
 US8685734
 US2014099666
 US8697417
 US8734809
 WO2014144229
 WO2014178863
 US2014359799
 US8946152
 WO2015038958
 US8999948
 US2015126590
 US2015159173
 WO2015121501
 US2015238550
 WO2015137802
 US9163261
 WO2015168666
 US2015315612
 US9193769
 WO2015191508
 US2015376607
 US2015376240
 US9233131
 US9238800
 US2016017295
 US2016017005
 US2016032254
 WO2016049230
 WO2016065001
 WO2016073693
 WO2016077687
 WO2016077689
 WO2016094783
 WO2016134375
 WO2016137949
 US9475845
 US2016369298
 WO2017015102
 WO2017023724
 WO2017058892
 US9624274
 WO2017066764
 WO2017075335
 WO2017083722
 US2017145405
 WO2017100671
 WO2017189963
 WO2017189959
 WO2017189964
 WO2017201258
 WO2017201248
 US2018258424
 WO2018204786
 WO2018204803
 WO2018204797
    - TRATSCHIN et al., Mol. Cell Biol., (19850000), vol. 5, no. 11, pages 3251 - 3260
    - GRIMM, Hum. Gene Ther., (19990000), vol. 10, no. 15, pages 2445 - 2450
    - CHIORINI et al., J. Vir., (19970000), vol. 71, pages 6823 - 33
    - SRIVASTAVA et al., J. Vir., (19830000), vol. 45, pages 555 - 64
    - CHIORINI et al., J. Vir., (19990000), vol. 73, pages 1309 - 1319
    - RUTLEDGC et al., J. Vir., (19980000), vol. 72, pages 309 - 319
    - WU et al., J. Vir., (20000000), vol. 74, pages 8635 - 47
    - PARRET, Nat. Med, (19970000), vol. 3, pages 1145 - 9
    - YU et al., Molecular Pain, (20110000), vol. 7, page 63
    - GILL et al., Gene Therapy, (20010000), vol. 8, pages 1323 - 1332
    - PASSINIWOLFE, J. Virol., (20010000), pages 12382 - 12392
    - DREWS et al., "Identification of evolutionary conserved, fimctional noncoding elements in the promoter region of the sodium channel gene SCN8A", Mamm Genome, (20070000), vol. 18, pages 723 - 731
    - RAYMOND et al., "Expression of Alternatively Spliced Sodium Channel a-subunit genes", Journal of Biological Chemistry, (20040000), vol. 279, no. 44, pages 46234 - 46241
    - THOMAS. G., Nature Reviews Molecular Cell Biology, (20020000), vol. 3, no. 10, pages 753 - 66
    - KIM, J.H. et al., PLoS One, (20110000), vol. 6, no. 4, page e 185s6
    - GEORGE. R.A. et al., Protein Engineering, (20020000), vol. 15, no. 11, pages 871 - 9
    - HUSTON, J.S et al., PNAS, (19880000), vol. 85, pages 5879 - 83
    - SHAN, D. et al., Journal of Immunology, (19990000), vol. 162, no. 11, pages 6589 - 95
    - N PULICHERLA et al., Molecular Therapy, (20110000), vol. 19, no. 6, pages 1070 - 1078
    - GRIMM et al., Journal of Virology, (20080000), vol. 82, no. 12, pages 5887 - 5911
    - DEVERMAN et al., Nature Biotechnology, (20160000), vol. 34, no. 2, pages 204 - 209
    - CHAN et al., Nature Neuroscience, (20170000), vol. 20, no. 8, pages 1172 - 1179
    - JIN. et al., "Direct Liquid Chromatography/Mass Spectrometry Analysis for Complete Characterization of Recombinant Adeno-Associated Virus Capsid Proteins", Hum Gene Ther Methods, (20171000), vol. 28, no. 5, pages 255 - 267
    - HWANG et al., "N-Terminal Acetylation of Cellular Proteins Creates Specific Degradation Signals", Science, (20100219), vol. 327, no. 5968, doi:10.1126/science.1183147, pages 973 - 977, XP055369420

DOI:   http://dx.doi.org/10.1126/science.1183147
    - ELBASHIR SM et al., Nature, (20010000), vol. 411, pages 494 - 498
    - SHEEHAN B, Ther Adv Neurol Disord, (20120000), vol. 5, no. 6, pages 349 - 358
    - T. E. CREIGHTON, Proteins: Structure and Molecular Properties, W.H. Freeman & Co., (19830000), pages 79 - 86
    - J. Mol Biol, (19970000), vol. 266, no. 4, pages 814 - 830
    - STILWELLSAMULSKI et al., Biotechniques, (20030000), vol. 34, page 148
    - STEPHEN F. ALTSCHULTHOMAS L. MADDENALEJANDRO A. SCHAFFERJINGHUI ZHANGZHENG ZHANGWEBB MILLERDAVID J. LIPMAN, "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs", Nucleic Acids Res., (19970000), vol. 25, doi:10.1093/nar/25.17.3389, pages 3389 - 3402, XP002905950

DOI:   http://dx.doi.org/10.1093/nar/25.17.3389
    - KOZAK, M, Cell, (19860131), vol. 44, no. 2, pages 283 - 92
    - KOZAK, M., J Cell Biol., (19890200), vol. 108, no. 2, pages 229 - 41
    - KOZAK, M., Mamm Genome, (19960800), vol. 7, no. 8, pages 563 - 74
    - CLARK et al., Hum. Gene Ther, (19990000), vol. 10, pages 1031 - 1039
    - VELDWIJK et al., Mol. Ther., (20020000), vol. 6, pages 272 - 278
    - SAMULSKI et al., J. Vir, (19890000), vol. 63, pages 3822 - 8
    - KAJIGAYA et al., Proc Nat'l. Acad. Sci USA, (19910000), vol. 88, pages 4646 - 50
    - RUFFING et al., J. Vir., (19920000), vol. 66, pages 6922 - 30
    - KIMBAUER et al., Vir., (19960000), vol. 219, pages 37 - 44
    - ZHAO et al., Vir., (20000000), vol. 272, pages 382 - 93
    - LUCKOW et al., Bio/Technology, (19880000), vol. 6, page 47
    - URABE. M. et al., J Virol., (20060200), vol. 80, no. 4, pages 1874 - 85
    - WASILKO DJ et al., Protein Expr Purif., (20090600), vol. 65, no. 2, pages 122 - 32
    - FENG, L. et al., Biotechnol Appl Biochem., (20080000), vol. 50, pages 121 - 32
    - SMITH, R.H. et al., Mol. Ther., (20090000), vol. 17, no. 11, pages 1888 - 96
    - KOTIN. R.M., Human Molecular Genetics, (20110000), vol. 20, no. 1, pages R2 - R6
    - MATHUPALA, Expert Opin Ther Pat., (20090000), vol. 19, pages 137 - 140
    - CHEMICAL ABSTRACTS, Database accession no. 7647-14-15
    - POTTER et al., Cerebrovasc Dis., (20150100), vol. 39, no. 4, pages 224 - 231
    - MACLULLICH et al., J Neurol Neurosurg Psychiatry, (20041100), vol. 75, no. 11, pages 1519 - 23
    - VINCENT et al., Neuromotecular medicine, (20040000), vol. 6, pages 79 - 85
    - WANG et al., J Neurosci., (20020000), vol. 22, pages 6920 - 6928
    - G. S. BANKER, Modem Pharmaceutics, Drugs and the Pharmaceutical Sciences, Marcel Dekker, New York, Inc., (19960000), vol. 72
 US19950462014
 US19950549489
 WO1996US10245
 WO1997US15716
 WO1997US15691
 WO1998US19479
 WO1998US19463
 WO1999US05870
 WO2000US00415
 WO2000US04755
 US20000659203
 WO2000US40872
 WO2004US16614
 US20050246447
 US20060465302
 WO2007US10055
 WO2018US42391
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.